To peek or not to peek after 32 cases? Exploring that question in Biontech/Pfizer’s vaccine trial
This is my 4th post about Biontech/Pfizer’s Covid-19 vaccine trial. If you are missing background, please first look at my 2nd post and 3rd post. Biontech/Pfizer originally planed to analyze...continue reading.